SITC 2026 is the premier international conference focused on cancer immunotherapy, bringing together leaders from academia, regulatory agencies, government, and industry for education, scientific exchange, and networking.
The conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy.
Why attend SITC 2026?
- Cutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)
- In-person networking opportunities with IO luminaries
- Access the latest immuno-oncology research
Location: Phoenix Convention Center, Phoenix, Arizona, United States
Key Dates:
Regular and early career investigator award abstract submission deadline: 25 June 2026
Abstract notifications: 31 July 2026
Late-breaking abstract submission deadline: 10 September 2026
Abstract notifications: 28 September 2026